QuantumScape has spent the week posting one of its sharpest rallies in months, up 16% in five days to $8.42, with news that the solid-state battery maker is targeting AI and defense licensing opportunities adding fuel to a stock that has been heavily shorted all year.
The short position here is genuinely large and has been growing. Short interest in QS has climbed from around 17.5% of the free float at the start of April to nearly 20% by late April, before ticking back modestly to 19.6% as of May 12. That month-long build — roughly 12% more shares short over 30 days — tells you bears were actively rebuilding into the Q1 earnings print on April 22, when the stock jumped 6% on the day. The five-day reaction was less positive, giving back around 2%, but bears who added before results have now seen those positions marked against them as the stock rallied hard this week. Yet shorts have barely flinched: the short count dropped just 1.3% over the week, a muted response to a 16% price move. That divergence is the story.
The lending market offers an important nuance. Despite the heavy short position, borrow conditions have actually loosened considerably this week. Cost to borrow dropped from around 1.1% last week to 0.47% today, the lowest level of the past month. Availability, while still tight relative to a pre-April-rally baseline, has eased alongside the CTB decline. The lending market is telling you that shorts are not being squeezed — they have room to hold, and new supply is coming into the pool as longs who rode the rally decide to let their shares out. The ORTEX short score of 73.3 remains elevated, sitting only marginally below the 74.6 peak of late April, underscoring that the overall short configuration remains stretched even as this week's pressure eased slightly.
Options traders are not adding to the defensive tone. The put/call ratio is running at 0.28, fractionally below its 20-day average of 0.29 and well beneath the 52-week high of 0.51. There is no unusual demand for downside protection. If anything, call activity has been dominant all month, consistent with a speculative, high-beta name where the options market tilts bullish. The lack of a hedging response after a 16% rally is notable — call buyers appear to be chasing the move rather than defending against reversal.
The insider picture is persistently one-directional. Over the past 90 days the company's insiders have sold approximately $6 million of stock. The CFO Kevin Hettrich, Founder and CTO Timothy Holme, Chief Legal Officer Michael McCarthy, and director Jeffrey Straubel all sold shares in April, largely at prices between $6.17 and $6.98. Most recently, a Chief Level Officer sold 50,000 shares at $7.87 on May 6, just as the rally was picking up pace. These sales appear to be programmatic in nature — spread across multiple executives, relatively small individually — but the aggregate direction is clear: management has been using rallies to reduce exposure.
The Street has been cautious on fundamentals, and the data largely validates that view. QS generates zero revenue and burns roughly $255 million annually in operating cash. The price-to-book multiple has expanded sharply, rising more than 1 full turn over the past 30 days to 5.1x as the share price re-rated. The most recent analyst data available — from Morgan Stanley and Evercore in late February — carried mean price targets in the $8–$10 range against a stock now at $8.42. That data is now close to three months old and should be treated carefully; the current price has essentially converged with the prior target range, leaving limited implied upside from the last published Street consensus. The next earnings event is scheduled for June 3, which gives the market roughly three weeks to digest the licensing-pivot narrative before management updates guidance.
What to watch next: whether the short position finally cracks below 19% of the float as the stock holds above the analyst target zone, or whether shorts use any pullback to rebuild again ahead of the June 3 earnings date.
See the live data behind this article on ORTEX.
Open QS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
